Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oji

Showing results (511-520 of 589) with videos related to

Pageof 59
Sort By:
Frontiers in Neurology|January 18, 2024
Factor analysis for construct validity of a trunk impairment scale in Parkinson's disease: a cross-sectional studyKazunori Sato, Yuta Yamazaki, Yoshihiro Kameyama, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 7, 2021
Cellular and Humoral Immune Responses Induced by an HLA Class I-restricted Peptide Cancer Vaccine Targeting WT1 Are Associated With Favorable Clinical Outcomes in Advanced Ovarian CancerSumiyuki Nishida, Soyoko Morimoto, Yusuke Oji, et al.
International Journal of Hematology|January 15, 2008
Wilms tumor gene WT1 peptide-based immunotherapy induced a minimal response in a patient with advanced therapy-resistant multiple myelomaAkihiro Tsuboi, Yoshihiro Oka, Hiroko Nakajima, et al.
Cancer Science|December 1, 2011
Biased usage of T cell receptor β-chain variable region genes of Wilms' tumor gene (WT1)-specific CD8+ T cells in patients with solid tumors and healthy donorsSoyoko Morimoto, Yoshihiro Oka, Akihiro Tsuboi, et al.
Cancer Science|August 7, 2003
Overexpression of the Wilms' tumor gene WT1 in colorectal adenocarcinomaYusuke Oji, Hirofumi Yamamoto, Masaya Nomura, et al.
Oncogene|May 12, 2015
Deficiency in WT1-targeting microRNA-125a leads to myeloid malignancies and urogenital abnormalitiesN Tatsumi, N Hojo, O Yamada, et al.
Cancer Science|October 27, 2004
Overexpression of the Wilms' tumor gene W T1 in primary astrocytic tumorsYusuke Oji, Tsuyoshi Suzuki, Yoko Nakano, et al.
Cancer Science|February 9, 2010
High frequencies of less differentiated and more proliferative WT1-specific CD8+ T cells in bone marrow in tumor-bearing patients: an important role of bone marrow as a secondary lymphoid organAyako Murao, Yoshihiro Oka, Akihiro Tsuboi, et al.
Orthopaedic Journal of Sports Medicine|May 5, 2025
Are Large Language Model-Based Chatbots Effective in Providing Reliable Medical Advice for Achilles Tendinopathy? An International Multispecialist EvaluationZuru Liang, Ming Wang, Nasef Mohamed Nasef Abdelatif, et al.
Leukemia|March 5, 2004
Preferential expression of the vasoactive intestinal peptide (VIP) receptor VPAC1 in human cord blood-derived CD34+CD38- cells: possible role of VIP as a growth-promoting factor for hematopoietic stem/progenitor cellsM Kawakami, T Kimura, Y Kishimoto, et al.
Pageof 59

Showing results (511-520 of 589) with videos related to

Sort By:
Pageof 59
Frontiers in Neurology|January 18, 2024
Factor analysis for construct validity of a trunk impairment scale in Parkinson's disease: a cross-sectional studyKazunori Sato, Yuta Yamazaki, Yoshihiro Kameyama, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 7, 2021
Cellular and Humoral Immune Responses Induced by an HLA Class I-restricted Peptide Cancer Vaccine Targeting WT1 Are Associated With Favorable Clinical Outcomes in Advanced Ovarian CancerSumiyuki Nishida, Soyoko Morimoto, Yusuke Oji, et al.
International Journal of Hematology|January 15, 2008
Wilms tumor gene WT1 peptide-based immunotherapy induced a minimal response in a patient with advanced therapy-resistant multiple myelomaAkihiro Tsuboi, Yoshihiro Oka, Hiroko Nakajima, et al.
Cancer Science|December 1, 2011
Biased usage of T cell receptor β-chain variable region genes of Wilms' tumor gene (WT1)-specific CD8+ T cells in patients with solid tumors and healthy donorsSoyoko Morimoto, Yoshihiro Oka, Akihiro Tsuboi, et al.
Cancer Science|August 7, 2003
Overexpression of the Wilms' tumor gene WT1 in colorectal adenocarcinomaYusuke Oji, Hirofumi Yamamoto, Masaya Nomura, et al.
Oncogene|May 12, 2015
Deficiency in WT1-targeting microRNA-125a leads to myeloid malignancies and urogenital abnormalitiesN Tatsumi, N Hojo, O Yamada, et al.
Cancer Science|October 27, 2004
Overexpression of the Wilms' tumor gene W T1 in primary astrocytic tumorsYusuke Oji, Tsuyoshi Suzuki, Yoko Nakano, et al.
Cancer Science|February 9, 2010
High frequencies of less differentiated and more proliferative WT1-specific CD8+ T cells in bone marrow in tumor-bearing patients: an important role of bone marrow as a secondary lymphoid organAyako Murao, Yoshihiro Oka, Akihiro Tsuboi, et al.
Orthopaedic Journal of Sports Medicine|May 5, 2025
Are Large Language Model-Based Chatbots Effective in Providing Reliable Medical Advice for Achilles Tendinopathy? An International Multispecialist EvaluationZuru Liang, Ming Wang, Nasef Mohamed Nasef Abdelatif, et al.
Leukemia|March 5, 2004
Preferential expression of the vasoactive intestinal peptide (VIP) receptor VPAC1 in human cord blood-derived CD34+CD38- cells: possible role of VIP as a growth-promoting factor for hematopoietic stem/progenitor cellsM Kawakami, T Kimura, Y Kishimoto, et al.
Pageof 59